Outcomes Research in Review
Officials at the American Society of Clinical Oncology are seeking approval of the model as a payment option in Medicare.
NATIONAL HARBOR, MD. – In a phase 1/2 trial of previously untreated advanced melanoma patients, the combination of bempegaldesleukin and nivolumab...
Almost half of patients with cancer did not use anything to manage related symptoms, according to an ASCO poll.
Reasons include metastasis and refusal, and rates by state vary from 8% to 30%, the American Lung Association reports.
Dr. Stephen S. Grubbs, of the American Society of Clinical Oncology, discusses the future of the Oncology Care Model and other options for value-...
Longer-than-expected survival times and substantial platinum sensitivity among women in the trial could have diluted an independent surgical...
AUSTIN, TEX. – “Timing of onset is a critical component to assist in identifying immune checkpoint inhibitor-associated versus non-immune...
VANCOUVER – Surgical staging outperforms CT scans, but a key question remains.
San Francisco – Even after implementation of National Comprehensive Cancer Network guidelines, blacks, Asians, and Hispanics less often receive...